Form D · Pharmaceuticals
BIOSORTIA PHARMACEUTICALS, INC.
San Diego, CA · CIK 0001516539
Offering snapshot reported Nov 5, 2019 · SEC filing
- Reported sold
- $675K Offering amount: $3.7M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Oct 25, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 5, 2019 | Initial | $675,000 | No comparison | 3 | SEC filing |
| Jul 5, 2017 | Initial | $170,000 | No comparison | 2 | SEC filing |
| Dec 2, 2016 | Amendment | $2,035,000 | $1,535,000vs Dec 29, 2015 | 15 | SEC filing |
| Aug 2, 2016 | Amendment | $1,535,000 | $1,035,000vs Dec 29, 2015 | 13 | SEC filing |
| Dec 29, 2015 | Initial | $500,000 | No comparison | 2 | SEC filing |
| May 27, 2015 | Initial | $1,565,000 | No comparison | 13 | SEC filing |
| Nov 12, 2014 | Initial | $502,500 | No comparison | 1 | SEC filing |
| Nov 12, 2014 | Initial | $502,500 | No comparison | 1 | SEC filing |
| Sep 10, 2014 | Amendment | $2,921,625 | $918,750vs Oct 28, 2013 | 21 | SEC filing |
| Oct 28, 2013 | Amendment | $2,002,875 | $1,777,875vs Jun 19, 2013 | 21 | SEC filing |
| Jun 19, 2013 | Initial | $225,000 | No comparison | 1 | SEC filing |
| Dec 4, 2012 | Initial | $697,501 | No comparison | 2 | SEC filing |
| Mar 25, 2011 | Initial | $1,507,013 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-352675
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Nov 5, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Henry Cialone | Director |
| Kurt D Dieck | Director, Executive |
| Robert Kamerschen | Director |
| Ron Moss | Director |
| Douglas Poling | Director |
| Derrell Porter | Director |
| John Ryals | Director |
| Roger A. Vaughan | Director |
| Ross O Youngs | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3210 Merryfield Row Jlabs #5900 U
San Diego, CA, 92121
San Diego, CA, 92121